PEMBROLIZUMAB VS PLACEBO PLUS PACLITAXEL ± BEVACIZUMAB FOR PLATINUM-RESISTANT RECURRENT OVARIAN CANCER: RESULTS FROM THE PHASE 3 ENGOT-OV65/KEYNOTE-B96 STUDY
作者
Nicoletta Colombo,Emese Zsíros,Alexandra Sebastianelli,Mariusz Bidziński,Carlos Gallardo,Emad Matanes,Kosei Hasegawa,Fatih Köse,Manuel Magallanes,Rebecca Herbertson,Jeffrey C. Goh,Judith R. Kroep,Andréia Cristina de Melo,Philip R. Debruyne,Jae‐Weon Kim,Xuan Peng,Karin Yamada,Agata M. Bogusz,Thibault De La Motte Rouge,Xiaohua Wu